论文部分内容阅读
目的对输血前不规则血型抗体筛查在临床输血检验中所起的作用进行比较,探讨其临床应用价值。方法本次选择1600名受血者的临床资料进行抗体筛查,鉴定其抗体特异性和不规则阳性标本,回归性分析并统计其不规则抗体的检出率及特异性。结果所有受血者中6人被检出为阳性抗体,检出率为0.37%,其中4人患血液系统疾病,占比66.67%,比例超过其他疾病(33.33%),差异有效(P<0.05)。在不规则抗体特异性鉴定结果中,MNS系统抗体占33.3%,Rh系统抗体占66.7%。结论相较于常规盐水法检测,低离子聚凝胺技术能有效提高检出率,在当前条件下,应大力提倡和推广这一具有高可靠性和安全性的技术手段,维护受血者的健康和安全。输血前对患者不规则血型抗体筛查能在临床输血检验中起到积极作用,可以进行临床推广。
Objective To compare the role of screening irregular blood group antibody before transfusion in clinical blood transfusion test and discuss its clinical value. Methods The clinical data of 1,600 blood recipients were selected for antibody screening. The antibody specificity and irregular positive samples were identified. The detection rate and specificity of irregular antibodies were analyzed by regression analysis. Results Six of the recipients were detected as positive antibodies, with a detection rate of 0.37%. Four of them had hematologic diseases, accounting for 66.67%, accounting for more than other diseases (33.33%), with significant difference (P <0.05 ). In the results of the irregular antibody-specific assay, 33.3% of the MNS system antibodies and 66.7% of the Rh system antibodies. Conclusion Compared with the conventional salt water test, low-ion polybrene technology can effectively improve the detection rate. Under the current conditions, we should vigorously promote and promote this high reliability and safety of technical means to protect the recipients Health and safety. Pre-transfusion screening for patients with irregular blood group antibodies can play a positive role in clinical blood transfusion tests and can be clinically promoted.